The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease
Takahiko Sugihara(Shiga University of Medical Science), Akira Andoh(Shiga University of Medical Science), Hirotsugu Imaeda(Shiga University of Medical Science), Ayako Kobori(University of Illinois Chicago), Koji Takeuchi(National Institute of Environmental Health Sciences), Tomoyuki Tsujikawa, Yoshihide Fujiyama(Shiga University of Medical Science), Kikuko Amagase(Kyoto Pharmaceutical University)
Cited by 131
Related Papers
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
|Clinical Immunology|2003|491
Interleukin-22, a Member of the IL-10 Subfamily, Induces Inflammatory Responses in Colonic Subepithelial Myofibroblasts
|Gastroenterology|2005|477
Decreased abundance of <i><scp>F</scp>aecalibacterium prausnitzii</i> in the gut microbiota of <scp>C</scp>rohn's disease
|Journal of Gastroenterology and Hepatology|2012|301
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
|Journal of Gastroenterology|2010|252
Cross-sectional Imaging in Crohn Disease
|Radiographics|2004|242